
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy of Dupilumab in Children 6 Months to 11 Years Old With Atopic Dermatitis: A Retrospective Real-World Study in China
Nali Yang, Yahui Ye, Junyi Shao, et al.
Dermatitis (2023) Vol. 35, Iss. S1, pp. S39-S46
Closed Access | Times Cited: 13
Nali Yang, Yahui Ye, Junyi Shao, et al.
Dermatitis (2023) Vol. 35, Iss. S1, pp. S39-S46
Closed Access | Times Cited: 13
Showing 13 citing articles:
Real-world outcomes of children treated with dupilumab for moderate-to-severe atopic dermatitis: a single-centre retrospective observational UK study
Mozhgan Hosseini-Ashrafi, Tim H Clayton, Michelle Herring, et al.
Clinical and Experimental Dermatology (2024) Vol. 49, Iss. 6, pp. 578-583
Open Access | Times Cited: 9
Mozhgan Hosseini-Ashrafi, Tim H Clayton, Michelle Herring, et al.
Clinical and Experimental Dermatology (2024) Vol. 49, Iss. 6, pp. 578-583
Open Access | Times Cited: 9
The Association of Inflammatory Indexes Derived from Peripheral Blood Cell Count and Clinical Signs with Response to Treatment with Dupilumab in Pediatric Patients with Moderate-to-Severe Atopic Dermatitis
Lingzhao Zhang, Jiangshan Pi, Jinsong Wang, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 271-282
Open Access | Times Cited: 1
Lingzhao Zhang, Jiangshan Pi, Jinsong Wang, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 271-282
Open Access | Times Cited: 1
Real‐life retrospective multicentre study to describe the use of dupilumab in paediatric patients with atopic dermatitis in Spain: Patient profile, effectiveness and safety
Eulàlia Baselga Torres, Marta Ivars, Carolina Prat, et al.
JEADV Clinical Practice (2025)
Open Access
Eulàlia Baselga Torres, Marta Ivars, Carolina Prat, et al.
JEADV Clinical Practice (2025)
Open Access
Real-world efficacy and safety of dupilumab in children with atopic dermatitis under 6 years of age: a retrospective multicentric study
Filip Rob, Blanka Pinková, K. Yu. Sokolova, et al.
Journal of Dermatological Treatment (2025) Vol. 36, Iss. 1
Open Access
Filip Rob, Blanka Pinková, K. Yu. Sokolova, et al.
Journal of Dermatological Treatment (2025) Vol. 36, Iss. 1
Open Access
A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years
Cataldo Patruno, Gabriella Fabbrocini, Giuseppe Lauletta, et al.
Journal of Dermatological Treatment (2023) Vol. 34, Iss. 1
Open Access | Times Cited: 11
Cataldo Patruno, Gabriella Fabbrocini, Giuseppe Lauletta, et al.
Journal of Dermatological Treatment (2023) Vol. 34, Iss. 1
Open Access | Times Cited: 11
Monoclonal antibodies for moderate-to-severe atopic dermatitis: a look at phase III and beyond
Eden David, Kelly Hawkins, Neda Shokrian, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 6, pp. 471-489
Closed Access | Times Cited: 3
Eden David, Kelly Hawkins, Neda Shokrian, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 6, pp. 471-489
Closed Access | Times Cited: 3
A prospective observational cohort study comparing the treatment effectiveness and safety of ciclosporin, dupilumab and methotrexate in adult and paediatric patients with atopic dermatitis: results from the UK–Irish A-STAR register
H Alexander, Rayka Malek, David Prieto‐Merino, et al.
British Journal of Dermatology (2024) Vol. 191, Iss. 6, pp. 988-999
Open Access | Times Cited: 3
H Alexander, Rayka Malek, David Prieto‐Merino, et al.
British Journal of Dermatology (2024) Vol. 191, Iss. 6, pp. 988-999
Open Access | Times Cited: 3
Effectiveness and Safety of Dupilumab in Children Under 6 Years of Age with Moderate-to-Severe Atopic Dermatitis: A Retrospective Real-World Study
Emilio Berna‐Rico, Esther Fiz Benito, José Manuel Busto‐Leis, et al.
Dermatology (2023) Vol. 240, Iss. 2, pp. 337-342
Open Access | Times Cited: 7
Emilio Berna‐Rico, Esther Fiz Benito, José Manuel Busto‐Leis, et al.
Dermatology (2023) Vol. 240, Iss. 2, pp. 337-342
Open Access | Times Cited: 7
Dupilumab treatment in paediatric atopic dermatitis (2 to 18 years): Spanish multicentre retrospective real-life study
Helena Iznardo, Esther Roé, Asunción Vicente, et al.
Clinical and Experimental Dermatology (2024)
Closed Access | Times Cited: 1
Helena Iznardo, Esther Roé, Asunción Vicente, et al.
Clinical and Experimental Dermatology (2024)
Closed Access | Times Cited: 1
Mid-Term Efficacy of Dupilumab in Children Aged ≥ 36 Months to <12 Years With Atopic Dermatitis: A Case Series
Francisco Javier Melgosa Ramos, Tania Díaz Corpas, Sergio Martín Jiménez, et al.
Actas Dermo-Sifiliográficas (2024) Vol. 115, Iss. 6, pp. 625-627
Open Access
Francisco Javier Melgosa Ramos, Tania Díaz Corpas, Sergio Martín Jiménez, et al.
Actas Dermo-Sifiliográficas (2024) Vol. 115, Iss. 6, pp. 625-627
Open Access
Self-Assessment
Lawrence S. Feigenbaum, Jennifer K. Chen
Dermatitis (2024) Vol. 35, Iss. S1, pp. S1-S3
Closed Access
Lawrence S. Feigenbaum, Jennifer K. Chen
Dermatitis (2024) Vol. 35, Iss. S1, pp. S1-S3
Closed Access
[Artículo traducido] Eficacia a medio plazo de dupilumab en niños de ≥ 36 meses a < 12 años con dermatitis atópica: serie de casos
Francisco Javier Melgosa Ramos, Tania Díaz Corpas, Sergio Martín Jiménez, et al.
Actas Dermo-Sifiliográficas (2024) Vol. 115, Iss. 6, pp. T625-T627
Open Access
Francisco Javier Melgosa Ramos, Tania Díaz Corpas, Sergio Martín Jiménez, et al.
Actas Dermo-Sifiliográficas (2024) Vol. 115, Iss. 6, pp. T625-T627
Open Access
Dupilumab Improves Clinical Scores in Pediatric Patients Aged 2 to <18 Years with Uncontrolled Atopic Dermatitis: A Single-Center, Real-World Study
Yifei Wang, Chen Shen, Danping Liu, et al.
Dermatologic Therapy (2023) Vol. 2023, Iss. 1
Open Access
Yifei Wang, Chen Shen, Danping Liu, et al.
Dermatologic Therapy (2023) Vol. 2023, Iss. 1
Open Access